A Clinical Study Evaluating the Dermal Safety of Soluble Denosumab Microneedle Patches

Conditions

• Osteoarthritis
• Osteoarthritis (OA) of the Knee
• Osteoporosis
• Osteoporosis (Senile)
• Healthy

Interventions

• DRUG: Microneedle with 0.24mg Denosumab
• DRUG: Saline Microneedle Patch
• DRUG: Microneedle with 1.2mg Denosumab
• DRUG: Microneedle with 6mg Denosumab

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology